StonvexLoading…
StonvexStonvexStonvexCore line items from VRNS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $623.53M | $550.95M | $499.16M | $473.63M |
Operating Income | $-146.51M | $-117.65M | $-117.22M | $-121.23M |
Net Income | $-129.32M | $-95.77M | $-100.92M | $-124.52M |
EPS (Diluted) | $-1.13 | $-0.86 | $-0.92 | $-1.14 |
Total Assets | $1.79B | $1.66B | $1.10B | $1.04B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $202.48M | $185.59M | $230.74M | $367.80M |
Free Cash Flow OCF − CapEx | $134.80M | $108.51M | $54.32M | $475.00K |
Shares Outstanding | 117.55M | 112.55M | 109.10M | 107.67M |